Lipid formulations of amphotericins: are you a lumper or a splitter?
Wingard
John R
JR
D000666:Amphotericin B / Q000009:adverse effects / Q000737:chemistry* / Q000627:therapeutic use; D000935:Antifungal Agents / Q000009:adverse effects / Q000737:chemistry* / Q000627:therapeutic use; D002626:Chemistry, Pharmaceutical; D006801:Humans; D008055:Lipids / Q000737:chemistry*; D016896:Treatment Outcome
D000935:Antifungal Agents; D008055:Lipids; D000666:Amphotericin B